3D Tissue Models
Stem Cells for Drug Developers
Revere Hotel Boston Common
200 Stuart Street
Boston, USA
Stem Cells for Drug Developers
Revere Hotel Boston Common
200 Stuart Street

Schedule of Presentations:

Tuesday, March 19, 2013
06:00:00 New Presentation
09:00:00 The Challenges of Incorporating Multiple Differentiated Cell Types from Patient Derived iPS Cells to Definitively Model Diseased Tissues John Hambor
13:00:00 Developing High Content Screening Tools Using Patient Specific iPS Cells to Discover Novel Therapeutic Compounds
Wednesday, March 20, 2013
07:45:00 Registration, Coffee & Networking
08:25:00 Chair’s Opening Remarks Gary A. Gintant
08:30:00 Developing Drug Discovery Programs Using Pluripotent Stem Cells: A Pharma Insider’s Four Year Perspective
09:00:00 Using Stem Cell Derived Cells to Develop More Predictive Assays
09:30:00 Characterization and Utilization of iPS Derived Cardiomyocytes in Early Predictive Screening Dinesh Puppala
10:00:00 Speed Networking Session & Morning Refreshments
10:30:00 Validation of an iPSC Based Drug Screening Platform to be Used to Identify Novel Small Molecules Active in Promoting Chondrogenesis Paul August
11:30:00 Using Stem Cell-Derived Cardiomyocytes as Novel In Vitro Models to Study Human Cardiac Toxicity
12:00:00 ESCs and iPSCs as Simple, Reproducible and Cost-Effective Tools for Toxicity Testing Hirdesh Uppal
12:30:00 Lunch & Networking
14:00:00 Validating Stem Cell-Based Assays and Models for Drug Safety and Discovery Gary A. Gintant
14:30:00 Round Table Discussion: How can Pharma Validate Stem Cell-Derived Models as Being Better than Current Models for Screening and Tox Studies?
15:00:00 Afternoon Refreshments & Networking
15:30:00 Using ESC Models as a Tool for Therapeutic Target Discovery Wojtek Auerbach
16:00:00 Phenotypic Screening Using Stem-Cell Derived Mature Cardiomyocytes to Identify Novel Therapeutic Targets Christine Ivashchenko
16:30:00 Pluripotent Stem Cell-Derived Hepatocytes Recapitulate the Pathophysiology of Familial Hypercholesterolemia
17:00:00 Chair’s Closing Remark
Thursday, March 21, 2013
06:00:00 New Presentation
08:00:00 Registration, Coffee & Networking
08:55:00 Chair’s Opening Remarks Ilyas Singec
09:00:00 Keynote Efficient Generation of Potent Vasculogenic Cells Rakesh K Jain
09:30:00 New Approaches to Create a 3D Retinal Disease Model Deepak Lamba
10:00:00 Round Table Discussion: Gaining Access to Patient Samples and Using Stem Cell Lines
10:30:00 Morning Refreshments & Networking
11:00:00 A Defined and Robust In Vitro System to Differentiate hESCs/iPSCs into Functional Blood Cells
11:30:00 Industrial Approach for Neuronal Differentiation of Patient Derived iPS cells for Modeling Alzheimer's Disease
12:00:00 Patient iPSCs as a Model for Accelerated Cardiovascular Disease Drug Discovery Roberto Iacone
12:30:00 Lunch & Networking
13:30:00 Towards a Pancreatic Cell Fate: Strategies for Characterization and Function
14:00:00 Phospho-Proteomic Profiling of Neural Lineage Entry Using Human Pluripotent Stem Cells Ilyas Singec
15:00:00 Therapeutic Potential of Pluripotent Stem Cells for Muscular Dystrophies Radbod Darabi
15:30:00 Round Table Discussion: Filling a Need in the Market Place: What Terminally Differentiated Cell Types should we be Prioritizing?
16:00:00 Chair’s Closing Remarks
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.